Philip Arlen

Company: Precision BioLogic

Job title: President & Chief Executive Officer

Seminars:

Targeting Tumour Neoepitopes with Monoclonal Antibodies 2:00 pm

Employing a unique cancer vaccine platform to develop monoclonal antibodies against functional tumour neo-antigens Utilising innovative technologies and expertise in immunology, in addition to unique antibody display platforms with an automated high throughput screening Using these antibodies to identify the precise neoantigen targetedRead more

day: Day Two